However, loss of CD44 significantly correlates with poor survival when associated with a corresponding loss in E-cadherin, especially in Stage II CRC, suggesting that CD44 and E-cadherin may have an inter-dependent role in suppressing invasion and metastasis [113]. Here, CD44 is linked to colorectal carcinoma.